Cart
sales@molnova.com
ELOVL6-IN-2
CAS No. 1067647-43-1
ELOVL6-IN-2( —— )
Catalog No. M23274 CAS No. 1067647-43-1
ELOVL6-IN-2 is a orally active and selective ELOVL6 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 31 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 207 | In Stock |
|
| 100MG | 309 | In Stock |
|
| 200MG | 442 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameELOVL6-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionELOVL6-IN-2 is a orally active and selective ELOVL6 inhibitor.
-
DescriptionELOVL6-IN-2 is a orally active and selective ELOVL6 inhibitor.
-
In Vitro——
-
In VivoAnimal Model:Male C57BL/6J mice Dosage:0.1~1mg/kg Administration:P.o Result:Potently and dose-proportionally suppressed the elongation index in the liver.Animal Model:Male C57BL/6J mice Dosage:10 mg/kg Administration:P.o Result:Demonstrated highly liver penetrable.Animal Model:Male C57BL/6J mice Dosage:1 mg/kg Administration:P.o Result:Exhibited sustained plasma exposure.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorELOVL6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1067647-43-1
-
Formula Weight579.49
-
Molecular FormulaC28H23F6N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:90mg/ml(155.31mM; Need ultrasonic)
-
SMILESCC(C)(CC(N1c2ccccc2)=C2C(C(F)(F)F)(C(C3=O)=C(C)NN3c(cc3)ccc3OC(F)(F)F)C1=O)CC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.[J]. Journal of Medicinal Chemistry, 2009, 52(10):3142.
molnova catalog
related products
-
Crenulatin
Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
-
S961 TFA (1083433-49...
S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.
-
Ginsenoside Rd
Ginsenoside Rd may have properties that inhibit or prevent the growth of tumors.
